Medical diagnostic kit requires more frequent calibration than Instructions stated
The Instructions for Use for Siemens' Atellica IM BR 27.29 Test Kit incorrectly specified a 10-day calibration interval instead of 3 days. The manufacturer has updated the instructions for all kit lots.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II medical device used for cancer antigen detection. While no illnesses or injuries have been reported, the incorrect calibration interval in the Instructions for Use represents a risk-of-harm scenario—inaccurate calibration schedules could result in degraded diagnostic accuracy. Under the severity rubric, risk-of-harm products where injury has not yet been reported score as High (3).
Plain-English summary
Siemens Healthcare Diagnostics, Inc. is recalling the Atellica IM BR 27.29 Assay 250 Test Kit, which is used for in vitro diagnostic testing to measure cancer antigen CA 27.29 levels in human blood samples. The recall is due to incorrect instructions provided with the kit.
The Instructions for Use (IFU) claimed a calibration interval of 10 days, but the correct interval is 3 days. Siemens has corrected the IFU to specify the 3-day calibration interval for all current and future kit lot numbers.
The recall affects approximately 787 units distributed worldwide, including to the United States, Australia, Bahamas, India, Mexico, Saudi Arabia, and Vietnam. Affected lot numbers include 41331255, 74682255 (expiring August 3, 2021), and 91605257 (expiring November 10, 2021).
Healthcare facilities and laboratories using this product should implement the corrected 3-day calibration interval as specified in the updated instructions.
The recalled product
- Product
- Atellica IM BR 27.29 (BR) Assay 250 Test Kit (Reference)- in vitro diagnostic use in the quantitative serial determination of cancer antigen CA 27.29 in human serum and plasma (EDTA) using the Atellica IM Analyzer.- SMN: 11206236
- Manufacturer
- Siemens Healthcare Diagnostics, Inc
- Affected units
- 787
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot number: 91605257 expiration date 2021-11-10.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Siemens Healthcare Diagnostics, Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · calibration error
See all →- ModeratePhotera 400 Phototherapy Device Recalled for Incorrect UV Sensor Calibration
FDA (Devices) · 2026-07-22
- ModeratePhotera 600 3-D phototherapy device UV sensor calibration error recall
FDA (Devices) · 2026-07-22
- ModeratePhotera 600 Phototherapy Device UV Sensor Calibration Error
FDA (Devices) · 2026-07-22
- HighPhothera 200 phototherapy calibration certificates had outputs reversed
FDA (Devices) · 2026-06-10
- HighRoche cobas analyzer may repeat previous results for spline calibrated assays
FDA (Devices) · 2026-03-11